http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0623680-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d669af06cb2abbcd6823699582a97002
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
filingDate 1994-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_300ab8885160f09c8dbbda847c1e1ec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_370429006b8a062f824dd2dc666ba9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c1db1c79eaaf0f0fdaf631e0dd03bb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_831502f57fce6d8edcc9795f82d773df
publicationDate 1994-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0623680-A1
titleOfInvention Process to synthesize peptides and its use
abstract 2.1. The enzymatic synthesis of peptides is advantageously achieved by means of proteases, but the hydrolysis of the acylenzyme intermediate associated with the formation of the peptide product and further possible proteolytic cleavages pose a problem in many synthesis reactions. As a result, the yield of peptide product remains limited and the separation of by-products is difficult. The new biocatalytic peptide production should take place with the greatest possible exclusion of undesirable proteolytic side reactions.n n n 2.2. The biocatalytic production of a peptide is advantageous if a zymogen is used instead of the protease that is usually used. Since zymogens are proteolytically still inactive precursors of proteases, proteolytic side reactions are largely suppressed. Amino acid esters or peptide esters and C-terminally derivatized amino acids or peptide fragments are preferably coupled to one another. The reaction can also take place in a frozen aqueous medium. Chymotrypsinogen, trypsinogen, pepsinogen, prorennin or pro-carboxypeptidase are particularly suitable as zymogens.n n n 2.3. Enzymatic or biocatalyzed peptide synthesis.
priorityDate 1993-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9119811-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397853
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97398
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35002
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100862683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12961
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13289
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420991868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673752
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396344
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396345
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491441
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410504465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672000
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452337993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394753
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050

Total number of triples: 59.